ABSTRACT-The kinetics and mechanism of sn-1,2-diacylglycerol (DAG) formation induced by isoprenaline were studied in rat parotid acinar cells. DAG accumulation induced by 100 pM isoprenaline reached its maximum at 1 min, rapidly decreased (about 50%) at 5 min and then remained constant for 30 min. DAG accumulation 1 min after isoprenaline treatment was dose-dependent. Either propranolol or phentolamine inhibited isoprenaline-stimulated DAG accumulation in a dose-dependent manner. Addition of a vasoactive intestinal polypeptide, forskolin, or dibutyryl cyclic AMP had no effect on DAG accumula tion. Isoprenaline did not cause the release of [3H]choline or [3H]ethanolamine metabolites into the medium. Based on the kinetics of DAG formation and [32P]phosphoinositide breakdown, we conclude that isoprenaline-induced DAG formation was mainly related to the hydrolysis of [32P]phosphatidylinositol 4,5 bisphosphate ([32P]PIP2). These results suggest that the effect of isoprenaline on DAG formation is mediated by a,-adrenoceptor activation, that it is not related to the increase in cyclic AMP, and that it is closely related to PIP2 hydrolysis.
ABSTRACT-The kinetics and mechanism of sn-1,2-diacylglycerol (DAG) formation induced by isoprenaline were studied in rat parotid acinar cells. DAG accumulation induced by 100 pM isoprenaline reached its maximum at 1 min, rapidly decreased (about 50%) at 5 min and then remained constant for 30 min. DAG accumulation 1 min after isoprenaline treatment was dose-dependent. Either propranolol or phentolamine inhibited isoprenaline-stimulated DAG accumulation in a dose-dependent manner. Addition of a vasoactive intestinal polypeptide, forskolin, or dibutyryl cyclic AMP had no effect on DAG accumula tion. Isoprenaline did not cause the release of [3H]choline or [3H]ethanolamine metabolites into the medium. Based on the kinetics of DAG formation and [32P]phosphoinositide breakdown, we conclude that isoprenaline-induced DAG formation was mainly related to the hydrolysis of [32P]phosphatidylinositol 4,5 bisphosphate ([32P]PIP2). These results suggest that the effect of isoprenaline on DAG formation is mediated by a,-adrenoceptor activation, that it is not related to the increase in cyclic AMP, and that it is closely related to PIP2 hydrolysis. Various agonists cause phospholipase C-dependent phosphoinositide hydrolysis through the receptor-G pro tein system and stimulate the release of two putative sec ond messengers, inositol 1,4,5-phosphate (1,4,5-IP3) and sn-1,2-diacylglycerol (DAG) (1) (2) (3) (4) (5) . DAG may activate a protein kinase C and thus play an important role in the process leading to exocytosis (6) . The mechanism of DAG formation, however, is not fully understood, because its kinetics vary with the agonist and cell type. It is reported that high (> 100 rM) concentrations of isoprenaline mobilize intracellular Ca 21 in parotid acinar cells (7 9). Horn et al. (7) reported that the intracellular Ca 21 mobilization caused by isoprenaline was related to the activation of (32-adrenoceptors and is mediated through a mechanism involving cyclic AMP. In contrast, Hughes et al. (8) and Tanimura et al. (9) found that the increase in intracellular Ca 21 mobilization elicited by isoprenaline was mediated by non-specific stimulation of a-adrenoceptors through the intermediate action of 1,4,5 IP3, but was not related to cyclic AMP. Thus, there are conflicting reports on the mechanism by which isoprena line induces intracellular Ca 21 mobilization.
To clarify the signal transduction provoked by 100 ,uM isoprenaline in parotid acinar cells, we sought to charac terize the kinetics and the mechanism of DAG formation. This study demonstrates that isoprenaline induces DAG formation by activation of a,-adrenoceptors, not (3-recep tors, and that it is closely related to the hydrolysis of phos phatidylinositol 4,5-bisphosphate (PIP2), but not to that of phosphatidylcholine or phosphatidylethanolamine. Cell preparation Parotid acinar cells from male Wistar rats (180-200 g) were obtained by enzymatic digestion as described previ ously (10) . Cells (106 cells/ml) were incubated in a HEPES-buffered Krebs-Henseleit medium composed of: 98 mM NaCl, 5 mM KC1, 1.3 mM CaC12, 1.2 mM MgSO4i 2.4 mM NaHCO3i 10 mM Na-HEPES, 11 mM dextrose and 1 % (w/v) bovine serum albumin. The medium also contained essential amino acids and was maintained at pH 7.4 under an atmosphere of 95% oxygen and 5 % car bon dioxide. All experiments were carried out at 371C.
MATERIALS AND METHODS

Materials
DAG assay
After the cells (106 cells/ml) were stimulated with agonist, lipids were extracted with a chloroform/ methanol mixture (1 : 2, v/v), and the DAG levels in the lipid extracts of acinar cells were measured by a highly sen sitive assay using [r-32P]ATP, as previously described by Preiss et al. (11) . This assay depends on the measurement of the mass of the DAG converted from DAG to 
Assay of [32PJphosphoinositides
Phosphoinositide breakdown was measured in cells loaded with carrier-free "Pi (15 iCi/ml) for 90 min, as described previously by Komabayashi et al. (12) . After removal of the labeling medium, the cells were rinsed twice with fresh medium and then stimulated with agonist for the indicated periods. [3H]Choline or [3H]ethanolamine-labeled metabolites released into the medium were quantitated as previously described by Komabayashi et al. (12) . To express the results as the net release of [3H]choline or [3H]ethanol amine metabolites, the amounts at time 0 were subtracted from each value.
Data analyses
All data are expressed as the mean ± S. E. The sig nificance of difference between means was determined by Student's t-test. P values <0.05 were considered to indi cate a significant difference. In each figure where S.E. bars are not shown, they are within the symbols. 
RESULTS
Time and dose-dependent increase of DAG formation in response to isoprenaline
Over 30 min of stimulation, DAG formation evoked by 100 tiM isoprenaline reached its maximum at 1 min and the levels thereafter remained relatively constant up to 30 min, except for a rapid decrease (about 50%) at 5 min (Fig. 1) . Concentrations of isoprenaline less than 1 pM did not stimulate DAG formation (data not shown). At concentrations greater than 1 pM, the isoprenaline response that occurred at 1 min was dose-dependent ( Fig. 2) .
Effects of some adrenoceptor antagonists on isoprenaline induced DAG accumulation Figure 3 shows the effects of propranolol and phentola mine on isoprenaline-induced DAG accumulation. The in crease in DAG accumulation due to 100 pM isoprenaline was inhibited by either a or (3-adrenoceptor antagonists in a dose-dependent manner. The effect of isoprenaline was also blocked by prazosin (10 pM), a selective a, adrenoceptor antagonist (data not shown). We further ex amined the effect of these antagonists on phenylephrine stimulated DAG generation. DAG formation evoked by 20 pM phenylephrine reached its maximum at 1 min, and this effect was significantly inhibited by propranolol (100 pM), phentolamine (10 pM), and prazosin (1 pM) (data not shown). This would imply that propranolol, a (3 adrenoceptor antagonist, is capable of blocking a adrenoceptors. Propranolol and phentolamine each had no effect on basal DAG accumulation. Effects of vasoactive intestinal polypeptide, forskolin, and dibutyryl cyclic AMP on DAG accumulation We studied the relationship between cyclic AMP and DAG accumulation.
Vasoactive intestinal polypeptide and forskolin can increase cyclic AMP levels in parotid glands (13, 14) . As shown in Table 1 , vasoactive intestinal polypeptide, forskolin, and dibutyryl cyclic AMP had no significant effect on DAG accumulation.
Effect of staurosporine on isoprenaline-induced DAG accumulation Activation of a protein kinase C stimulates DAG for mation in several cell types (15) (16) (17) . Staurosporine (0.1 pM), which is a putative protein kinase C inhibitor (18) , significantly inhibits amylase release and DAG formation elicited by phorbol ester, carbachol, and cholecystokinin in pancreatic and parotid acinar cells (10, 19) . As shown in Fig. 4 , isoprenaline-evoked DAG accumulation was not sensitive to staurosporine treatment, which was not the case with carbachol stimulation (10 In the next series of experiments, we examined the effect of prazosin, an a,-adrenoceptor antagonist, on isoprenaline-induced
[32P]PIP2 breakdown. As shown in Fig. 7 , prazosin significantly blocked the effect of iso prenaline. 
DISCUSSION
The main finding of our study is that isoprenaline stimu lates DAG formation via a,-adrenoceptors and that this effect is closely associated with PIP2 hydrolysis.
At concentrations from 10-9 M to 10-6 M, isoprena line stimulates amylase release from parotid acinar cells in a dose-dependent manner (9, 14) . The present study shows that DAG accumulation caused by isoprenaline oc curred from 10-6 M to 2 x 10-4 M (Fig. 2) . These data are similar to the results of Tanimura et al. (9) , who found that isoprenaline from 10-6 M to 10-3 M dose-dependent ly stimulates intracellular Ca 21 mobilization. These obser vations suggest that the increase in intracellular Ca 21 mobilization and DAG levels that are evoked by high (> 1 ttM) concentrations of isoprenaline is not required for amylase release.
It is known that isoprenaline has a little affinity for a-adrenoceptors and that the ~-adrenoceptor antagonist propranolol also inhibits a-adrenoceptors (9, 20, 21) . In fact, 100 pM propranolol inhibited not only isoprenaline induced DAG accumulation but also phenylephrine-in duced DAG accumulation. This finding suggests that the actions of propranolol were not restricted to f3-adrenocep tors. This is explained by the binding affinity of proprano lol for a-adrenoceptors, as described above. In addition, isoprenaline had affinity for a-adrenoceptors, as shown by results that isoprenaline-stimulated DAG accumula tion was dose-dependently inhibited by phentolamine (Fig. 3 ). This finding is in agreement with the data report ed by Tanimura et al. (9) , who found that isoprenaline induced increases in intracellular Ca 21 mobilization were inhibited by phentolamine in a dose-dependent manner. The [32P]PIP2 breakdown elicited by isoprenaline was also inhibited by prazosin (Fig. 7) . Taken together, these results are in agreement with those reported by Hughes et al. (8) and Tanimura et al. (9) , and suggest that iso prenaline-induced DAG accumulation is related to al adrenoceptor activation but not (3-adrenoceptors (see below). It is thought that phosphatidylcholine is an im portant source of DAG in many cell types. Phosphatidyl choline hydrolysis mediated through phospholipase D produces PA, and DAG is generated from PA through the intermediate action of PA phosphohydrolase. This PA activity is inhibited by high concentrations of propranolol (22, 23) . Isoprenaline, however, had no effect on phos phatidylcholine hydrolysis in this system (Fig. 8) , suggest ing that the effect of propranolol on isoprenaline-stimulat ed DAG formation is not related to inhibition of PA phos phohydrolase.
In contrast, Horn et al. (7) reported that isoprenaline stimulated PIP2 turnover and mobilized Ca 21 from an intracellular Ca2+ pool via a mechanism involving j32 adrenoceptors and cyclic AMP. Therefore, the possibility that an increase in cyclic AMP is involved in the isoprena line-stimulated DAG accumulation can not be completely excluded. As shown in Table 1 , the addition of vasoactive intestinal polypeptide and forskolin had no effect on DAG accumulation. Furthermore, dibutyryl cyclic AMP (1 mM), a permeable cyclic AMP analogue, did not stimu late DAG accumulation. These results are in agreement with those of Tanimura et al. (9) and suggest that cyclic AMP accumulation is not involved in DAG generation. Therefore, the effect of isoprenaline on DAG formation does not appear to be mediated by the 132-adrenoceptor cyclic AMP system.
Although the source of 1,4,5-IP3 is PIP2, DAG can also be produced by phospholipase C cleavage of PIP or PI, in addition to PIP2 (5, (24) (25) (26) (27) . In the parotid gland, both PIP and PIP2, but not PI, are mainly hydrolyzed by phos pholipase C through receptor activation (12, 28, 29) . In this study, the kinetics of DAG formation induced by 100 pM isoprenaline was very similar to that of [32p]PIP2 breakdown, but was not similar to those of [32P]PI and [32P]PIP breakdown (Fig. 5) . Furthermore, the break down of [3H]PIP2 at 1 min was dose-dependent (Fig. 6) . These results indicate that isoprenaline-evoked DAG for mation is predominantly related to [32P]PIP2 breakdown. Since [32P]PIP breakdown, however, temporarily in creased at 1 min, the DAG cleaved from PIP may be partially involved in DAG accumulation at 1 min (Fig. 5) . This increase in [3H]PIP2 breakdown is not due to the decrease in total labeling of phosphatidylinositol, because the [32P]PI increase was observed during stimulation.
The hydrolysis of phosphatidylcholine or phos phatidylethanolamine also increases the DAG level dur ing stimulation with an agonist (15, 16, (30) (31) (32) (33) (34) . Phos phatidylcholine hydrolysis is mediated via a protein kinase C. The present data show that isoprenaline did not stimulate the release of [3H]choline metabolites ( Fig. 8) and that DAG formation induced by isoprenaline was not inhibited by staurosporine (18), a protein kinase C inhibi tor (Fig. 4) . These results suggest that a protein kinase C-dependent mechanism is not involved in this effect. Matozaki and Williams (30) reported that phos phatidylethanolamine hydrolysis, although small, was stimulated with cholecystokinin-8 in rat pancreatic acini.
In this study, we show that isoprenaline did not stimulate the release of [3H]ethanolamine metabolites. Moreover, we obtained similar results after stimulation with sub stance P or carbachol (12, 35) . Perhaps, phosphatidyl ethanolamine hydrolysis may not be associated directly with DAG generation in the parotid gland. Together, these findings suggest that the effect of isoprenaline on DAG formation is mainly related to the hydrolysis of PIP2 as described above, and is not related to the hy drolysis of phosphatidylcholine or phosphatidylethanol amine.
In conclusion, our findings indicate that isoprenaline-in duced DAG formation is mediated via a1-adrenoceptors and is closely associated with PIP2 hydrolysis. Data also provide evidence that cyclic AMP was not involved in isoprenaline-stimulated DAG formation.
